JJ Bienaimé, departing BioMarin CEO
November 1, 2023 05:46 PM EDTUpdated November 2, 09:01 AM
People

JJ Bi­en­aimé is mov­ing out of the C-suite af­ter an 18-year run at Bio­Marin. And you like­ly know his suc­ces­sor

John Carroll

Editor & Founder

Feisty, stub­born Jean-Jacques Bi­en­aimé is step­ping down from the top post at Bio­Marin af­ter an 18-year run with a string of high­lights in 2023. And …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times